rs169793

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_198904.4(GABRG2):​c.769+10003T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.592 in 152,084 control chromosomes in the GnomAD database, including 26,963 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.59 ( 26963 hom., cov: 32)

Consequence

GABRG2
NM_198904.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0930

Publications

3 publications found
Variant links:
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRG2 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 74
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 8
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.654 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198904.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
NM_198904.4
MANE Select
c.769+10003T>A
intron
N/ANP_944494.1
GABRG2
NM_198903.2
c.889+10003T>A
intron
N/ANP_944493.2
GABRG2
NM_001375343.1
c.889+10003T>A
intron
N/ANP_001362272.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
ENST00000639213.2
TSL:1 MANE Select
c.769+10003T>A
intron
N/AENSP00000491909.2
GABRG2
ENST00000414552.6
TSL:1
c.889+10003T>A
intron
N/AENSP00000410732.2
GABRG2
ENST00000639111.2
TSL:1
c.769+10003T>A
intron
N/AENSP00000492125.2

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
90040
AN:
151966
Hom.:
26949
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.661
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.548
Gnomad ASJ
AF:
0.545
Gnomad EAS
AF:
0.394
Gnomad SAS
AF:
0.487
Gnomad FIN
AF:
0.590
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.587
Gnomad OTH
AF:
0.603
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.592
AC:
90088
AN:
152084
Hom.:
26963
Cov.:
32
AF XY:
0.589
AC XY:
43785
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.661
AC:
27429
AN:
41498
American (AMR)
AF:
0.547
AC:
8356
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.545
AC:
1889
AN:
3468
East Asian (EAS)
AF:
0.393
AC:
2032
AN:
5170
South Asian (SAS)
AF:
0.487
AC:
2349
AN:
4822
European-Finnish (FIN)
AF:
0.590
AC:
6230
AN:
10554
Middle Eastern (MID)
AF:
0.582
AC:
170
AN:
292
European-Non Finnish (NFE)
AF:
0.587
AC:
39882
AN:
67982
Other (OTH)
AF:
0.605
AC:
1278
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1882
3765
5647
7530
9412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.485
Hom.:
1430
Bravo
AF:
0.594
Asia WGS
AF:
0.439
AC:
1526
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.3
DANN
Benign
0.40
PhyloP100
0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs169793; hg19: chr5-161541035; COSMIC: COSV62716471; API